Correlation Between Thunder Bridge and PharmChem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Thunder Bridge and PharmChem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Thunder Bridge and PharmChem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Thunder Bridge Capital and PharmChem, you can compare the effects of market volatilities on Thunder Bridge and PharmChem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Thunder Bridge with a short position of PharmChem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Thunder Bridge and PharmChem.

Diversification Opportunities for Thunder Bridge and PharmChem

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Thunder and PharmChem is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Thunder Bridge Capital and PharmChem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PharmChem and Thunder Bridge is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Thunder Bridge Capital are associated (or correlated) with PharmChem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PharmChem has no effect on the direction of Thunder Bridge i.e., Thunder Bridge and PharmChem go up and down completely randomly.

Pair Corralation between Thunder Bridge and PharmChem

Assuming the 90 days horizon Thunder Bridge Capital is expected to generate 0.49 times more return on investment than PharmChem. However, Thunder Bridge Capital is 2.05 times less risky than PharmChem. It trades about 0.06 of its potential returns per unit of risk. PharmChem is currently generating about 0.01 per unit of risk. If you would invest  1,075  in Thunder Bridge Capital on September 24, 2024 and sell it today you would earn a total of  167.00  from holding Thunder Bridge Capital or generate 15.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.2%
ValuesDaily Returns

Thunder Bridge Capital  vs.  PharmChem

 Performance 
       Timeline  
Thunder Bridge Capital 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Thunder Bridge Capital has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively uncertain basic indicators, Thunder Bridge unveiled solid returns over the last few months and may actually be approaching a breakup point.
PharmChem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PharmChem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Thunder Bridge and PharmChem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Thunder Bridge and PharmChem

The main advantage of trading using opposite Thunder Bridge and PharmChem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Thunder Bridge position performs unexpectedly, PharmChem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PharmChem will offset losses from the drop in PharmChem's long position.
The idea behind Thunder Bridge Capital and PharmChem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes